NYSE:MED Medifast - MED Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $109.05 -5.17 (-4.53%) (As of 01/30/2023 03:49 PM ET) Add Compare Share Share Today's Range$108.99▼$114.1850-Day Range$111.79▼$130.3152-Week Range$96.00▼$204.14Volume136,722 shsAverage Volume133,191 shsMarket Capitalization$1.19 billionP/E Ratio8.27Dividend Yield5.74%Price Target$128.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Medifast MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside15.9% Upside$128.00 Price TargetShort InterestBearish5.50% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-2.06Upright™ Environmental ScoreNews Sentiment0.59Based on 5 Articles This WeekInsider TradingAcquiring Shares$60,222 Bought Last QuarterProj. Earnings Growth2.00%From $13.00 to $13.26 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.36 out of 5 starsConsumer Staples Sector48th out of 138 stocksMiscellaneous Food Preparations & Kindred Products Industry2nd out of 5 stocks 2.0 Analyst's Opinion Consensus RatingMedifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $128.00, Medifast has a forecasted upside of 15.9% from its current price of $110.47.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.50% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Medifast has recently increased by 17.81%, indicating that investor sentiment is decreasing significantly. Previous Next 3.3 Dividend Strength Dividend LeadershipMedifast is a leading dividend payer. It pays a dividend yield of 5.74%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthMedifast has only been increasing its dividend for 2 years.Dividend CoverageThe dividend payout ratio of Medifast is 49.73%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Medifast will have a dividend payout ratio of 49.47% next year. This indicates that Medifast will be able to sustain or increase its dividend. Previous Next 3.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedifast has received a 29.01% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Meal replacement drinks", "Granola without added sugar", and "Protein shakes" products. See details.Environmental SustainabilityThe Environmental Impact score for Medifast is -2.06. Previous Next 3.1 News and Social Media Coverage News SentimentMedifast has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Medifast this week, compared to 4 articles on an average week.Search Interest20 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows7 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have bought more of their company's stock than they have sold. Specifically, they have bought $60,222.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.30% of the stock of Medifast is held by insiders.Percentage Held by Institutions86.03% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Medifast are expected to grow by 2.00% in the coming year, from $13.00 to $13.26 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 8.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.21.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 8.38, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 15.03.Price to Book Value per Share RatioMedifast has a P/B Ratio of 6.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Medifast (NYSE:MED) StockMedifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.Read More Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Stock News HeadlinesJanuary 24, 2023 | marketwatch.comWeight Loss Diet Market Players to drive Merges and Acquisition Strategies to Expand Market Share, 2023-2027January 4, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)January 30, 2023 | Investing Trends (Ad)Solar Industry at Start of Long Bull Run?The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.January 3, 2023 | msn.comOptavia Diet Review: Everything You Need to KnowDecember 30, 2022 | finance.yahoo.comMedifast (MED) Banks on OPTAVIA Strength Amid Cost WoesDecember 28, 2022 | finance.yahoo.com7 Ridiculously Cheap Stocks Yielding 5% in 2023December 14, 2022 | finance.yahoo.com15 Biggest Diet/Weight Loss Companies in the WorldDecember 9, 2022 | seekingalpha.comMedifast Stock Shows Promise At Current ValuationJanuary 30, 2023 | Investing Trends (Ad)Solar Industry at Start of Long Bull Run?The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.December 5, 2022 | finance.yahoo.comMedifast Survey Indicates Consumer Focus on Health and Wellbeing Remains StrongNovember 26, 2022 | marketwatch.comWeight Loss and Diet Management Market Size And Opportunities for New Players, Forecast from 2022 To 2028 with Top Countries DataNovember 26, 2022 | marketwatch.comWeight Loss Services Market 2023 : Trend Analysis, Competitive Outlook of Top Industry Players and Future Expansion by 2028November 22, 2022 | msn.comMedifast's Return on Invested Capital InsightsNovember 16, 2022 | finance.yahoo.comMedifast Named to the 2022 FORTUNE 100 Fastest-Growing Companies ListNovember 9, 2022 | finance.yahoo.comMedifast Third Quarter 2022 Earnings: Beats ExpectationsNovember 4, 2022 | finance.yahoo.comMedifast to raise prices amid profit, revenue declineNovember 4, 2022 | finance.yahoo.comMedifast (MED) Cuts View Despite Q3 Earnings Beat, Stock DownNovember 2, 2022 | finance.yahoo.comMedifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021*November 1, 2022 | finance.yahoo.comMedifast's (MED) Q3 Earnings Upcoming: Things Worth NotingNovember 1, 2022 | finance.yahoo.comIs It Time To Consider Buying Medifast, Inc. (NYSE:MED)?October 25, 2022 | finance.yahoo.comMedifast, Inc. (MED)October 25, 2022 | ca.finance.yahoo.comThe Truth About the Optavia Diet, According to a NutritionistOctober 24, 2022 | finance.yahoo.comNew Medifast Survey Identifies Factors Associated with Successful Long-Term Weight LossOctober 20, 2022 | finance.yahoo.comMedifast to Announce Financial Results for the Third Quarter Ended September 30, 2022October 17, 2022 | finance.yahoo.com10 Best Weight Loss Stocks To Buy Now - Yahoo FinanceOctober 14, 2022 | nasdaq.comThese High-Yield Dividend Stocks Are Growing at Blazing Speeds - NasdaqOctober 3, 2022 | finance.yahoo.comOrganic Cereal Market 2026, Health Benefits Of Organic Cereals to Boost Growth - Technavio - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Company Calendar Ex-Dividend for 11/8 Dividend9/19/2022Last Earnings11/03/2022Dividend Payable11/08/2022Ex-Dividend for 2/7 Dividend12/19/2022Today1/30/2023Dividend Payable2/07/2023Next Earnings (Estimated)2/22/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees984Year FoundedN/APrice Target and Rating Average Stock Price Forecast$128.00 High Stock Price Forecast$150.00 Low Stock Price Forecast$106.00 Forecasted Upside/Downside+17.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$13.19 Trailing P/E Ratio8.27 Forward P/E Ratio8.39 P/E GrowthN/ANet Income$164.03 million Net Margins9.22% Pretax Margin12.10% Return on Equity89.82% Return on Assets42.20% Debt Debt-to-Equity RatioN/A Current Ratio1.49 Quick Ratio0.55 Sales & Book Value Annual Sales$1.53 billion Price / Sales0.78 Cash Flow$14.05 per share Price / Cash Flow7.76 Book Value$17.43 per share Price / Book6.26Miscellaneous Outstanding Shares10,930,000Free Float10,676,000Market Cap$1.19 billion OptionableOptionable Beta1.18 Key ExecutivesDaniel R. ChardExecutive Chairman & Chief Executive OfficerAnthony TyreeChief Business Operations OfficerJames P. MaloneyChief Financial OfficerNicholas M. JohnsonChief Field Operations OfficerLauren WalkerExecutive Vice President-Supply Chain OperationsKey CompetitorsUtz BrandsNYSE:UTZUniversalNYSE:UVVOatly GroupNASDAQ:OTLYFresh Del Monte ProduceNYSE:FDPBRCNYSE:BRCCView All CompetitorsInsiders & InstitutionsRice Hall James & Associates LLCSold 3,773 shares on 1/27/2023Ownership: 2.463%New York State Teachers Retirement SystemSold 987 shares on 1/27/2023Ownership: 0.172%Human Investing LLCBought 2,932 shares on 1/27/2023Ownership: 0.027%Campbell Newman Asset Management Inc.Sold 333 shares on 1/26/2023Ownership: 0.135%Inspire Investing LLCBought 133 shares on 1/26/2023Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions MED Stock - Frequently Asked Questions Should I buy or sell Medifast stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares. View MED analyst ratings or view top-rated stocks. What is Medifast's stock price forecast for 2023? 2 brokers have issued 1 year price objectives for Medifast's stock. Their MED share price forecasts range from $106.00 to $150.00. On average, they expect the company's share price to reach $128.00 in the next twelve months. This suggests a possible upside of 15.3% from the stock's current price. View analysts price targets for MED or view top-rated stocks among Wall Street analysts. How have MED shares performed in 2023? Medifast's stock was trading at $115.35 at the start of the year. Since then, MED stock has decreased by 3.8% and is now trading at $111.00. View the best growth stocks for 2023 here. Are investors shorting Medifast? Medifast saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 589,500 shares, an increase of 17.8% from the December 31st total of 500,400 shares. Based on an average trading volume of 138,400 shares, the short-interest ratio is presently 4.3 days. Approximately 5.5% of the shares of the stock are short sold. View Medifast's Short Interest. When is Medifast's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023. View our MED earnings forecast. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) issued its quarterly earnings results on Thursday, November, 3rd. The specialty retailer reported $3.32 EPS for the quarter, topping analysts' consensus estimates of $1.91 by $1.41. The specialty retailer earned $390.40 million during the quarter. Medifast had a trailing twelve-month return on equity of 89.82% and a net margin of 9.22%. How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast declared a quarterly dividend on Thursday, December 8th. Shareholders of record on Tuesday, December 20th will be given a dividend of $1.64 per share on Tuesday, February 7th. This represents a $6.56 dividend on an annualized basis and a dividend yield of 5.91%. The ex-dividend date of this dividend is Monday, December 19th. Read our dividend analysis for MED. Is Medifast a good dividend stock? Medifast (NYSE:MED) pays an annual dividend of $6.56 per share and currently has a dividend yield of 5.74%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 49.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MED will have a dividend payout ratio of 49.47% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for MED. What guidance has Medifast issued on next quarter's earnings? Medifast updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of $11.61-$13.05 for the period, compared to the consensus earnings per share estimate of $12.28. The company issued revenue guidance of $1.51 billion-$1.59 billion, compared to the consensus revenue estimate of $1.60 billion. What is Daniel Chard's approval rating as Medifast's CEO? 44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM). What is Medifast's stock symbol? Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED." Who are Medifast's major shareholders? Medifast's stock is owned by a number of institutional and retail investors. Top institutional investors include Rice Hall James & Associates LLC (2.46%), Chickasaw Capital Management LLC (0.26%), Allspring Global Investments Holdings LLC (0.20%), New York State Teachers Retirement System (0.17%), Campbell Newman Asset Management Inc. (0.14%) and National Bank of Canada FI (0.08%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes, Michael C Macdonald and Scott Schlackman. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Medifast's stock price today? One share of MED stock can currently be purchased for approximately $111.00. How much money does Medifast make? Medifast (NYSE:MED) has a market capitalization of $1.21 billion and generates $1.53 billion in revenue each year. The specialty retailer earns $164.03 million in net income (profit) each year or $13.19 on an earnings per share basis. How many employees does Medifast have? The company employs 984 workers across the globe. How can I contact Medifast? Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The official website for the company is www.medifast1.com. The specialty retailer can be reached via phone at (410) 581-8042, via email at ir@choosemedifast.com, or via fax at 410-581-8070. This page (NYSE:MED) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.